Related Experiment Videos
Management of vasovagal syncope
1Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21287, USA.
Journal of Cardiovascular Electrophysiology
|June 22, 1999
Summary
Vasovagal syncope, a common autonomic disorder, causes significant limitations. Current evidence suggests beta blockers, fludrocortisone, and alpha-adrenergic agonists may effectively treat this condition.
Area of Science:
- Cardiology
- Autonomic Neuroscience
Background:
- Vasovagal syncope is a prevalent disorder affecting autonomic cardiovascular regulation.
- It leads to significant psychosocial and physical limitations, impacting patient quality of life.
Observation:
- Optimal treatment strategies for vasovagal syncope are not well-established.
- Existing therapeutic approaches are primarily based on small, non-randomized studies, lacking robust clinical trial data.
Findings:
- Pharmacological agents with potential efficacy include beta blockers, fludrocortisone, and alpha-adrenergic agonists.
- A review of proposed therapeutic options and supporting clinical studies is presented.
Implications:
- Further large-scale prospective clinical trials are needed to confirm treatment efficacy.
- This review synthesizes current knowledge to guide the management of vasovagal syncope.